Investment
Features
FeesSafety
Academy
More
Pluang+

V2X wins $391M contract to support US Marine Corps equipment repair and logistics.

Market News
10 Aug 2026
PRNewsWire
View Source
Bullish
pluang ai news

V2X Inc. secured a contract worth approximately $391 million, potentially rising to $500 million, with the U.S. Marine Corps Logistics Command. The contract covers logistics integration support for the Marine Force Storage Command's Secondary Repairable program, focusing on coordinating repair and sustainment of critical equipment. This long-term partnership helps improve equipment availability and operational readiness by managing complex repair processes and supply chains. V2X's expertise in logistics and sustainment supports the Marine Corps' mission readiness and extends the life of essential assets.

More News

Optimism shifts 546.9M OP tokens from airdrop reserve to strategic fund

Optimism shifts 546.9M OP tokens from airdrop reserve to strategic fund

Optimism has moved 546.9 million OP tokens from its airdrop reserve to a strategic fund. This reallocation likely aims to support future growth initiatives or strategic investments. The move indicates a shift in resource management to better align wi...

Market News
Neutral
4 hours ago
Realty Income raises guidance and investment plans, maintaining buy rating amid solid growth and defensive dividend.

Realty Income raises guidance and investment plans, maintaining buy rating amid solid growth and defensive dividend.

Realty Income reported 3.8% growth in AFFO per share and raised its AFFO guidance to $4.44–$4.45, while increasing expected investment volume to $10 billion by 2026. The company’s strong balance sheet, attractive debt issuance, and expansion into Eur...

Company Fundamentals
Bullish
4 hours ago
Ecora Royalties shifts from coal to critical minerals but Q2 results show risks and margin pressure.

Ecora Royalties shifts from coal to critical minerals but Q2 results show risks and margin pressure.

Ecora Royalties is transitioning its focus from coal to critical minerals, but its Q2 financial results are affected by one-off factors and thus not a reliable baseline for future performance. The company's portfolio is heavily concentrated in the Vo...

Company Fundamentals
Bearish
4 hours ago
Neurocrine Biosciences rated 'Buy' on strong cash flow, key drug Ingrezza, and promising pipeline.

Neurocrine Biosciences rated 'Buy' on strong cash flow, key drug Ingrezza, and promising pipeline.

Neurocrine Biosciences is rated a 'Buy' due to its robust cash flows, strong product launches, and a diversified drug pipeline. Its main revenue driver, Ingrezza, holds exclusivity until 2038 with projected peak sales of $3.3 billion. Additional prod...

Analyst Insights
Bullish
4 hours ago
Ray Dalio advises 10-15% portfolio in gold and Bitcoin amid looming U.S. debt crisis fears.

Ray Dalio advises 10-15% portfolio in gold and Bitcoin amid looming U.S. debt crisis fears.

Ray Dalio, founder of Bridgewater Associates, recommends investors allocate 10-15% of their portfolios to gold and a small portion to Bitcoin, while reducing exposure to bonds. He cites growing U.S. political dysfunction and geopolitical tensions as ...

Market News
Bullish
5 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App